2.28 USD
↘ 0.02 (0.83%)PRE MARKET (AS OF 03:59 AM EST)
Rocket Pharmaceuticals, Inc. Common Stock (RCKT) trades at $2.28 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Nov 13, 2026.